Mainline Biosciences, Inc.
Records under this name other than the patents Mainline Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 5 of 5 · Back to Mainline Biosciences, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,870,681 | CXCR4 antagonists and methods of use Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,351,601 | CXCR4 antagonists and methods of use Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,639,379 | High affinity CXCR4 selective binding conjugate and method for using the same Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,883,501 | Selective CXCR4 binding peptide conjugate and methods for making and using the same Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,123,437 | Selective CXCR4 binding peptide conjugate and methods for making and using the same Formerly held Lapsed on the fee record Ended Sep 21, 2025 · USPTO record | Lapsed on the fee record | Ended Sep 21, 2025 | USPTO record |